Sun Pharma Patent Infringements

Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.

As per the terms of the settlement, Sun Pharma's subsidiary is entitled to launch its version of generic Angiomax in USA on June 30, 2019 or earlier under limited circumstances.

In November 2011, the company filed a patent infringement lawsuit against Sun, the release said.

Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix.

Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.

As per the terms of the settlement, Sun Pharma's subsidiary is entitled to launch its version of generic Angiomax in USA on June 30, 2019 or earlier under limited circumstances.

In November 2011, the company filed a patent infringement lawsuit against Sun, the release said.

Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix.